Literature DB >> 19949803

An uncommon illness with a rare presentation: neurosurgical management of ADEM with tumefactive demyelination in children.

Matthew VanLandingham1, William Hanigan, Vetta Vedanarayanan, Jonathan Fratkin.   

Abstract

PURPOSE: This study determined the statewide incidence and prevalence of acute disseminated encephalomyelitis (ADEM) and examined the course of three pediatric patients treated for tumefactive demyelination (TD) at the Blair E. Batson Children's Hospital.
METHODS: Analyses of ICD-9-CM code hospital records and clinical database were conducted.
RESULTS: From 2001 through 2007 the incidence in pediatric patients under 20 years was 0.4/100,000/year, with a prevalence of 8.6/100,000 during 2008. Three patients presented with TD. Case 1 had a 3-week history of ataxia and diplopia; case 2 presented with a sudden onset of coma, while the third child had a 4-month history of increasing lethargy and clumsiness in all extremities. Cerebrospinal fluid examinations were nondiagnostic. MRI examinations revealed asymmetric T2/fluid-attenuated inversion recovery hyperintensity within the pons (case 1), a large heterogenously enhancing temporal lobe mass, with extensive edema (case 2), and multiple small brain lesions with occasional ring enhancement (case 3). In case 1, intralesional MR spectroscopy demonstrated changes consistent with ADEM. Case 2 required intracranial monitoring, and medical treatment to control elevated ICP. Cases 2 and 3 underwent cortical biopsies that revealed ADEM. All three patients improved with corticosteroid therapy. At a minimum of 15 months follow-up, cases 1 and 2 showed resolution of deficits and MRI lesions, while the third patient demonstrated additional MRI lesions and increasing paraparesis.
CONCLUSIONS: These cases demonstrate that appropriate neuroradiological evaluation, treatment of acutely elevated ICP, and brain biopsy can play critical roles in the management of children with undiagnosed ADEM and TD.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19949803     DOI: 10.1007/s00381-009-1045-x

Source DB:  PubMed          Journal:  Childs Nerv Syst        ISSN: 0256-7040            Impact factor:   1.475


  29 in total

1.  Acute disseminated encephalomyelitis: MR imaging features.

Authors:  S Singh; M Alexander; I P Korah
Journal:  AJR Am J Roentgenol       Date:  1999-10       Impact factor: 3.959

2.  Acute disseminated encephalomyelitis, multiphasic disseminated encephalomyelitis and multiple sclerosis in children.

Authors:  R C Dale; C de Sousa; W K Chong; T C Cox; B Harding; B G Neville
Journal:  Brain       Date:  2000-12       Impact factor: 13.501

Review 3.  Acute disseminated encephalomyelitis.

Authors:  Enrico Marchioni; Eleonora Tavazzi; Lorenzo Minoli; Serena Del Bue; Pasquale Ferrante; Giovanni Piccolo; Stefano Bastianello; Sabrina Ravaglia
Journal:  Neurol Sci       Date:  2008-09       Impact factor: 3.307

4.  Acute disseminated encephalomyelitis presenting as a solitary brainstem mass.

Authors:  D H Miller; F Scaravilli; D C Thomas; P Harvey; N P Hirsch
Journal:  J Neurol Neurosurg Psychiatry       Date:  1993-08       Impact factor: 10.154

5.  Acute disseminated encephalomyelitis: a follow-up study of 40 adult patients.

Authors:  S Schwarz; A Mohr; M Knauth; B Wildemann; B Storch-Hagenlocher
Journal:  Neurology       Date:  2001-05-22       Impact factor: 9.910

Review 6.  Acute disseminated encephalomyelitis: an update.

Authors:  Til Menge; Bernhard Hemmer; Stefan Nessler; Heinz Wiendl; Oliver Neuhaus; Hans-Peter Hartung; Bernd C Kieseier; Olaf Stüve
Journal:  Arch Neurol       Date:  2005-11

7.  Central brain herniation secondary to fulminant acute disseminated encephalomyelitis: implications for neurosurgical management. Case report.

Authors:  Raymond F Sekula; Edward M Marchan; Parviz Baghai; Peter J Jannetta; Matthew R Quigley
Journal:  J Neurosurg       Date:  2006-09       Impact factor: 5.115

Review 8.  Can neurologic manifestations of Hughes (antiphospholipid) syndrome be distinguished from multiple sclerosis? Analysis of 27 patients and review of the literature.

Authors:  M J Cuadrado; M A Khamashta; A Ballesteros; T Godfrey; M J Simon; G R Hughes
Journal:  Medicine (Baltimore)       Date:  2000-01       Impact factor: 1.889

Review 9.  Acute disseminated encephalomyelitis.

Authors:  Silvia Tenembaum; Tanuja Chitnis; Jayne Ness; Jin S Hahn
Journal:  Neurology       Date:  2007-04-17       Impact factor: 9.910

10.  Evoked potential studies in the antiphospholipid syndrome: differential diagnosis from multiple sclerosis.

Authors:  D Paran; J Chapman; A D Korczyn; O Elkayam; O Hilkevich; G B Groozman; D Levartovsky; I Litinsky; D Caspi; Y Segev; V E Drory
Journal:  Ann Rheum Dis       Date:  2005-08-17       Impact factor: 19.103

View more
  1 in total

1.  Treatment of acute disseminated encephalomyelitis.

Authors:  Daniela Pohl; Silvia Tenembaum
Journal:  Curr Treat Options Neurol       Date:  2012-06       Impact factor: 3.972

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.